SCN1A and epilepsy: Our study has three key findings: (i) the SCN1A IVS5-91G>A SNP is associated with susceptibility to epilepsy, (ii) SNPs in EPHX1 gene influence CBZ pharmacokinetic and (iii) CBZ plasma level is not an indicator of resistance to the therapy.